Aav-epo for treating companion animals
AssigneeThe Trustees of the University of Pennsylvania
InventorsChristian Hinderer, James M. Wilson, Matthew Wilson
Life of this patent
Estimating the term…
Abstract
Compositions and methods are provided for treating companion animals are provided. An adeno-associated viral vector is provided which includes a nucleic acid molecule comprising a sequence encoding erythropoietin (EPO). In desired embodiments, the subject is a cat or dog.
Claims20
A recombinant adeno-associated virus (rAAV) comprising an AAV capsid having packaged therein a vector genome, wherein said vector genome comprises nucleic acid sequences encoding feline or canine erythropoietin (EPO), inverted terminal repeat sequences and expression control sequences that direct expression of the EPO in a host cell.
The rAAV of claim, wherein the expression control sequences comprise a promoter.
Dependencies are inferred from the claim text.